COGENT BIOSCIENCES INC's ticker is COGT and the CUSIP is 19240Q201. A total of 83 filers reported holding COGENT BIOSCIENCES INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $15,950,192 | +2.1% | 1,636,961 | +24.2% | 0.01% | 0.0% |
| Q2 2023 | $15,616,834 | -13.0% | 1,318,112 | -20.7% | 0.01% | -16.7% |
| Q1 2023 | $17,940,720 | -3.2% | 1,662,265 | +3.7% | 0.01% | -7.7% |
| Q4 2022 | $18,530,576 | -26.5% | 1,602,197 | -52.6% | 0.01% | -31.6% |
| Q3 2022 | $25,209,184 | +31.2% | 3,377,058 | +58.5% | 0.02% | +46.2% |
| Q2 2022 | $19,217,000 | -18.9% | 2,130,496 | -32.7% | 0.01% | +18.2% |
| Q1 2022 | $23,708,000 | +9.8% | 3,165,241 | +25.8% | 0.01% | +22.2% |
| Q4 2021 | $21,584,000 | +2.8% | 2,515,254 | +0.9% | 0.01% | 0.0% |
| Q3 2021 | $20,996,000 | +6.1% | 2,493,961 | +2.3% | 0.01% | +12.5% |
| Q2 2021 | $19,785,000 | -1.3% | 2,438,201 | +6.8% | 0.01% | -11.1% |
| Q1 2021 | $20,038,000 | +3.3% | 2,283,128 | +32.1% | 0.01% | 0.0% |
| Q4 2020 | $19,399,000 | – | 1,728,670 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 1,558,975 | $17,507,000 | 6.26% |
| COMMODORE CAPITAL LP | 760,025 | $8,535,000 | 4.64% |
| Ally Bridge Group (NY) LLC | 1,622,591 | $18,222,000 | 3.12% |
| Ghost Tree Capital, LLC | 1,100,000 | $12,353,000 | 2.75% |
| Logos Global Management LP | 1,920,500 | $21,567,000 | 1.85% |
| Altium Capital Management LP | 432,563 | $4,858,000 | 1.81% |
| VR Adviser, LLC | 1,088,817 | $12,227,000 | 1.80% |
| Atlas Venture Associates IX, LLC | 916,196 | $10,289,000 | 1.63% |
| Atlas Venture Associates XI, LLC | 916,196 | $10,289,000 | 1.63% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 235,066 | $2,640,000 | 1.53% |